Zobrazeno 1 - 10
of 358
pro vyhledávání: '"Volker, Limmroth"'
Publikováno v:
JMIR Formative Research, Vol 6, Iss 3, p e38002 (2022)
Externí odkaz:
https://doaj.org/article/c114dee636d54142b7380f0ef0af816d
Publikováno v:
JMIR Formative Research, Vol 6, Iss 3, p e31972 (2022)
BackgroundThe BETACONNECT autoinjector and myBETAapp app were designed to support patients with multiple sclerosis receiving interferon β-1b and are an ideal platform for digital observational studies. A recent pilot study in Germany demonstrated th
Externí odkaz:
https://doaj.org/article/bcbb154c754a45daa6239e4939de528d
Autor:
Clemens Warnke, Stephanie Stock, Martin Hellmich, Gereon R Fink, Heidrun Golla, Raymond Voltz, Judith Haas, Julia Strupp, Volker Limmroth, Anne Müller, Eckhard Bonmann, Kim Dillen, Thomas Dojan, Solveig Ungeheuer, Petra Schmalz, Angelika Staß, Vanessa Mildenberger, Yasemin Goereci, Veronika Dunkl, Oliver Cornely, Alexander Stahmann, Peter Löcherbach, Lothar Burghaus, Kathrin Gerbershagen, Gereon Nelles, Thomas Joist, Herbert Temmes
Publikováno v:
BMJ Open, Vol 12, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/aeb5d20b31af45b9a736d4b1e4a29421
Autor:
Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuss, Ralf Linker, Mathias Mäurer, Orhan Aktas, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czaplinski, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans-Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding-Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neuronal damage. The approval of various disease-modifying therapies and our increased understanding of
Externí odkaz:
https://doaj.org/article/cee55fa870514dd8bb41f4326e4ce63e
Autor:
Volker Limmroth, Tjalf Ziemssen, Ingo Kleiter, Bert Wagner, Stephan Schmidt, Christoph Lassek, Monika Baier-Ebert, Guillaume Wendt, Ralf Dechend, Wilhelm Haverkamp
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: First dose observation for cardiac effects is required for fingolimod. Previous results in patients with relapsing remitting multiple sclerosis (RRMS) suggest that transient bradycardia and conduction abnormalities during the observation
Externí odkaz:
https://doaj.org/article/9f1ad549b35345b1ba2cb7f3d101d2a6
Autor:
Felix Kohle, Marie Madlener, Emanuel Francesco Bruno, Gereon Rudolf Fink, Volker Limmroth, Lothar Burghaus, Michael Peter Malter
Publikováno v:
Journal of neurology 269(11), 5710-5719 (2022). doi:10.1007/s00415-022-11260-2
Background The “coronavirus disease 2019” (COVID-19) pandemic, caused by the “severe-acute-respiratory-syndrome-coronavirus 2” (SARS-CoV-2), challenges healthcare systems worldwide and impacts not only COVID-19 patients but also other emergen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14d0163efdede92f9146d64e548936bc
https://doi.org/10.1007/s00415-022-11260-2
https://doi.org/10.1007/s00415-022-11260-2
Autor:
Krista Barclay, Robert Carruthers, Anthony Traboulsee, Ann D. Bass, Christopher LaGanke, Antonio Bertolotto, Aaron Boster, Elisabeth G. Celius, Jérôme de Seze, Dionisio Dela Cruz, Mario Habek, Jong-Mi Lee, Volker Limmroth, Sven G. Meuth, Celia Oreja-Guevara, Patricia Pagnotta, Cindy Vos, Tjalf Ziemssen, Darren P. Baker, Bart Van Wijmeersch
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Multiple sclerosis (MS) is a chronic autoimmune neurological disease that typically affects young adults, causing irreversible physical disability and cognitive impairment. Alemtuzumab, administered intravenously as 2 initial courses of 12 mg/day (5
Externí odkaz:
https://doaj.org/article/5a2d464a5167440db92790a49c321afc
Publikováno v:
NeuroTransmitter. 33:37-39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3da7fef5bcd0e3b7d880ea1392bd1d73
https://doi.org/10.1007/s15016-022-9537-y
https://doi.org/10.1007/s15016-022-9537-y
Autor:
Volker Limmroth
Publikováno v:
InFo Neurologie + Psychiatrie. 25:12-13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6f07f47b4ba30fea146a1c99f93671a
https://doi.org/10.1007/s15005-023-3223-x
https://doi.org/10.1007/s15005-023-3223-x
Autor:
Martin S. Weber, Stefan Bittner, Claudio Gobbi, Hayrettin Tumani, Renaud Du Pasquier, Fedor Heidenreich, Ralf A. Linker, Frank Weber, Michael Platten, Martin Stangel, Andrew T. Chan, Heinz Wiendl, Olaf Hoffmann, Thomas Berger, Christian Enzinger, die Multiple Sklerose Therapie Konsensus Gruppe, Elisabeth Fertl, Mathias Mäurer, Orhan Aktas, Uwe K. Zettl, Ralf Gold, Boris Kallmann, Christoph Kleinschnitz, Florian Deisenhammer, Fritz Leutmezer, Jan D. Lünemann, Volker Limmroth, Zoë R. Hunter, Klaus Gehring, Aiden Haghikia, Verena I. Leussink, Franziska Di Pauli, Martin Berghoff, Michael Guger, Luisa Klotz, Tobias Derfuss, Tjalf Ziemssen, Stephan Schmidt, Uta Meyding-Lamadé, Hans-Peter Hartung, Sven G. Meuth, Frauke Zipp, Karl Baum, Achim Gass, Peter Rieckmann, Adam Czaplinski, Norbert Goebels, Andreas Lutterotti
Publikováno v:
Der Nervenarzt
Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neuronal damage. The approval of various disease-modifying therapies and our increased understanding of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150a5aeb37085c6f2116878af90b499b
http://europepmc.org/articles/PMC8300076
http://europepmc.org/articles/PMC8300076